EQT Fund Management S.a r.l.

Position in EVMN — Evommune, Inc.

CIK 1834239 LUXEMBOURG, N4

Position in EVMN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$113,332,262

+$28,936,946 QoQ

Shares Held

4,929,633

0.0% QoQ

Ownership

13.7%

of shares outstanding

% of Portfolio

11.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

EQT Fund Management S.a r.l. holds $420,905,779 across 4 Biotechnology names. EVMN ranks #2 (26.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	OCS	Oculis Holding AG	5,900,294	$156,888,817
2	EVMN	Evommune, Inc. This page	4,929,633	$113,332,262
3	PHVS	Pharvaris N.V.	3,424,609	$96,745,204
4	AGMB	Agomab Therapeutics NV	5,141,992	$53,939,496

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$113,332,262	4,929,633	0.0%	Shares	Sole	2026-05-14
2025-12-31	$84,395,316	4,929,633	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.